Atlantic Union Bankshares’s Vertex Pharmaceuticals VRTX Stock Holding History

Atlantic Union Bankshares’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.04M	Sell	14,182 -312	-2%	-$138K	0.12%	166
2026 Q1	$6.47M	Buy	14,494 +261	+2%	+$122K	0.12%	159
2025 Q4	$6.45M	Sell	14,233 -455	-3%	-$196K	0.12%	154
2025 Q3	$5.75M	Buy	14,688 +5,741	+64%	+$2.4M	0.11%	179
2025 Q2	$3.98M	Buy	8,947 +7,876	+735%	+$3.63M	0.09%	195
2025 Q1	$519K	Sell	1,071 -232	-18%	-$108K	0.03%	229
2024 Q4	$525K	Sell	1,303 -6,255	-83%	-$2.9M	0.03%	235
2024 Q3	$3.52M	Buy	7,558 +329	+5%	+$158K	0.2%	113
2024 Q2	$3.39M	Buy	7,229 +1,719	+31%	+$746K	0.21%	106
2024 Q1	$2.3M	Buy	5,510 +385	+8%	+$163K	0.19%	108
2023 Q4	$2.09M	Buy	5,125 +999	+24%	+$369K	0.19%	115
2023 Q3	$1.43M	Buy	4,126 +802	+24%	+$280K	0.15%	133
2023 Q2	$1.17M	Buy	3,324 +2,361	+245%	+$796K	0.12%	154
2023 Q1	$303K	Buy	+963	New	+$289K	0.03%	241

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Atlantic Union Bankshares's VRTX Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, selling an estimated $138K and leaving 14,182 shares worth $7.04M. The position accounts for 0.12% of the portfolio, ranked #166.

Atlantic Union Bankshares first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Atlantic Union Bankshares held 14,182 shares of Vertex Pharmaceuticals worth $7.04M as of Q2 2026.
Atlantic Union Bankshares sold 312 Vertex Pharmaceuticals shares in Q2 2026, an estimated $138K.
Vertex Pharmaceuticals made up 0.12% of Atlantic Union Bankshares's portfolio in Q2 2026, its #166 holding.
Atlantic Union Bankshares first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.